Iranian Red Crescent Medical Journal

Published by: Kowsar

Seroprevalence and Risk Factors of Hepatitis E in Eastern Iran

Zohreh Azarkar 1 , Azadeh Ebrahimzadeh 1 , * , Gholamreza Sharifzadeh 1 , Masood Ziaee 1 and Mohammad Fereidouni 2
Authors Information
1 Infectious Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran
2 Asthma, Allergy and Immunology Research Center, Birjand University of Medical Sciences, Birjand, Iran
Article information
  • Iranian Red Crescent Medical Journal: December 2017, 20 (S1); e41644
  • Published Online: April 8, 2017
  • Article Type: Research Article
  • Received: August 20, 2016
  • Revised: February 6, 2017
  • Accepted: February 27, 2017
  • DOI: 10.5812/ircmj.41644

To Cite: Azarkar Z, Ebrahimzadeh A, Sharifzadeh G, Ziaee M, Fereidouni M. Seroprevalence and Risk Factors of Hepatitis E in Eastern Iran, Iran Red Crescent Med J. 2017 ; 20(S1):e41644. doi: 10.5812/ircmj.41644.

Abstract
Copyright © 2017, Iranian Red Crescent Medical Journal. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Farshadpour F, Taherkhani R, Makvandi M. Prevalence of Hepatitis E Virus among Adults in South-West of Iran. Hepat Res Treat. 2015;2015:759589. doi: 10.1155/2015/759589. [PubMed: 26199756].
  • 2. Alvarado-Esquivel C, Sanchez-Anguiano LF, Hernandez-Tinoco J. Seroepidemiology of hepatitis e virus infection in general population in rural durango, Mexico. Hepat Mon. 2014;14(6). ee16876. doi: 10.5812/hepatmon.16876. [PubMed: 24976837].
  • 3. Abebe M, Ali I, Ayele S, Overbo J, Aseffa A, Mihret A. Seroprevalence and risk factors of Hepatitis E Virus infection among pregnant women in Addis Ababa, Ethiopia. PLoS One. 2017;12(6). e0180078. doi: 10.1371/journal.pone.0180078. [PubMed: 28650982]. [PubMed Central: PMC5484499].
  • 4. Ehteram H, Ramezani A, Eslamifar A, Sofian M, Banifazl M, Ghassemi S, et al. Seroprevalence of Hepatitis E Virus infection among volunteer blood donors in central province of Iran in 2012. Iran J Microbiol. 2013;5(2):172-6. [PubMed: 23825737].
  • 5. Avellon A, Morago L, Garcia-Galera del Carmen M, Munoz M, Echevarria JM. Comparative sensitivity of commercial tests for hepatitis E genotype 3 virus antibody detection. J Med Virol. 2015;87(11):1934-9. doi: 10.1002/jmv.24251. [PubMed: 25959136].
  • 6. Taherkhani R, Farshadpour F. Epidemiology of hepatitis E virus in Iran. World J Gastroenterol. 2016;22(22):5143-53. doi: 10.3748/wjg.v22.i22.5143. [PubMed: 27298557].
  • 7. Eick A, Ticehurst J, Tobler S, Nevin R, Lindler L, Hu Z, et al. Hepatitis E seroprevalence and seroconversion among US military service members deployed to Afghanistan. J Infect Dis. 2010;202(9):1302-8. doi: 10.1086/656598. [PubMed: 20863230].
  • 8. Azarkar Z, Miri MR, Arjmand S. Investigating the seroprevalence of hepatitis e among blood donors referring to blood donation centers in Birjand county in Iran. Modern Care J. 2016;13(1):27-31. doi: 10.17795/modernc.9456.
  • 9. Mooij SH, Hogema BM, Tulen AD, van Pelt W, Franz E, Zaaijer HL, et al. Risk factors for hepatitis E virus seropositivity in Dutch blood donors. BMC Infect Dis. 2018;18(1):173. doi: 10.1186/s12879-018-3078-9. [PubMed: 29653521]. [PubMed Central: PMC5899381].
  • 10. Sepanlou S, Rezvan H, Amini-Kafiabad S, Dayhim M, Merat S. A Population-based Seroepidemiological Study on Hepatitis E Virus in Iran. Middle East J Dig Dis. 2010;2(2):97-103. [PubMed: 25197520].
  • 11. Verhoef L, Koopmans M, Duizer E, Bakker J, Reimerink J, Van Pelt W. Seroprevalence of hepatitis E antibodies and risk profile of HEV seropositivity in The Netherlands, 2006-2007. Epidemiol Infect. 2012;140(10):1838-47. doi: 10.1017/S0950268811002913. [PubMed: 22269886].
  • 12. Cossaboom CM, Heffron CL, Cao D, Yugo DM, Houk-Miles AE, Lindsay DS, et al. Risk factors and sources of foodborne hepatitis E virus infection in the United States. J Med Virol. 2016;88(9):1641-5. doi: 10.1002/jmv.24497. [PubMed: 26889628].
  • 13. Kamar N, Abravanel F, Lhomme S, Rostaing L, Izopet J. Hepatitis E virus: chronic infection, extra-hepatic manifestations, and treatment. Clin Res Hepatol Gastroenterol. 2015;39(1):20-7. doi: 10.1016/j.clinre.2014.07.005. [PubMed: 25150374].
  • 14. Bai MJ, Zhou N, Dong W, Li GX, Cong W, Zhu XQ. Seroprevalence and risk factors of hepatitis E virus infection in cancer patients in eastern China. Int J Infect Dis. 2018;71:42-7. doi: 10.1016/j.ijid.2018.04.003. [PubMed: 29656134].
  • 15. Raoofi R, Nazer MR, Pournia Y. Seroepidemiology of hepatitis E virus in Western Iran. Braz J Infect Dis. 2012;16(3):302-3. doi: 10.1590/S1413-86702012000300017. [PubMed: 22729203].
  • 16. Cui W, Sun Y, Xu A, Gao R, Gong L, Zhang L. Hepatitis E seroprevalence and related risk factors among seafood processing workers: a cross-sectional survey in Shandong Province, China. Int J Infect Dis. 2016;49(62):6-56. doi: 10.1016/j.ijid.2016.05.028. [PubMed: 27265612].
  • 17. Mesquita JR, Myrmel M, Stene-Johansen K, Overbo J, Nascimento MS. A Public Health initiative on hepatitis E virus epidemiology, safety and control in Portugal--study protocol. BMC Infect Dis. 2016;16:17. doi: 10.1186/s12879-016-1341-5. [PubMed: 26774897].
  • 18. Echevarria JM. Light and Darkness: Prevalence of Hepatitis E Virus Infection among the General Population. Scientifica (Cairo). 2014;2014:481016. doi: 10.1155/2014/481016. [PubMed: 24672733].
  • 19. Faber MS, Wenzel JJ, Jilg W, Thamm M, Hohle M, Stark K. Hepatitis E virus seroprevalence among adults, Germany. Emerg Infect Dis. 2012;18(10):1654-7. doi: 10.3201/eid1810.111756. [PubMed: 23018055].
  • 20. Park HK, Jeong SH, Kim JW, Woo BH, Lee DH, Kim HY, et al. Seroprevalence of anti-hepatitis E virus (HEV) in a Korean population: comparison of two commercial anti-HEV assays. BMC Infect Dis. 2012;12:142. doi: 10.1186/1471-2334-12-142. [PubMed: 22726615].
  • 21. Tadesse E, Metwally L, Alaa E. High prevalence of anti-hepatitis E virus among Egyptian blood donors. J Gen Mol Virol. 2013;5(1):9-13.
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments